When suffering from back pain, especially if it is accompanied by walking difficulty and weakness in lower leg muscles, it is essential to discover the route of the problem. One possible explanation is that it could be symptoms of Cauda Equina syndrome.
Everyone hates cockroach to the core. They are the most problematic and omnipresent pest and simply won’t die so easily which is why they were able to successfully survive even after the extinction of many species.
Recently the FDA asked drug companies to stop selling sunscreen pills which and warned people not to fall for such scams as there are no pills which can replace sunscreen.
A new study was conducted by Paolo Bocchini, associate professor of civil and environmental engineering, Javier Buceta, an associate professor of bioengineering, and postdoctoral researcher Graziano Fiorillo. They were affiliated with the Lehigh University in Bethlehem, PA. They hypothesized that, since fruit bats carry the Ebola virus, tracking down their migratory patterns might give information about the time and location of the next outbreak.
There was a major breakthrough for scientists from Australia who designed a new blood test named “painHS” to detect chronic pain through color biomarkers.
A research team from the University of Toronto has designed a cost-effective 3D-handheld skin printer which can heal deep wounds in a matter of minutes, by evenly printing out skin layers on top of them.
There are numerous studies involving intestinal microbes like probiotics and its link with healthy intestines. But these host-microbe in other organs like the lungs were poorly understood, which led to inflammation.
American Health Insurance Company Anthem, Inc. announced that the company has signed an agreement to takeover Aspire Health, the nation’s largest non-hospice, community-based palliative care provider.
ClearCare Homecare Technology Company has developed HomeConnect Application Programming Interface – API which will help home care providers to connect directly to hospitals for referrals, care management, and billing.
Pharma giant Merck & Co. revealed Keytruda had perfectly completed its final-stage research on the drug for previously untreated patients with skin cancer, who represent about 25% to 30% of the overall market.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.